AAAAAA
Results:
1-15
|
Results: 15
Authors:
MORROW GR
BALLATORI E
GROSHEN S
OLVER I
Citation: Gr. Morrow et al., STATISTICAL CONSIDERATIONS IN THE DESIGN, CONDUCT AND ANALYSES OF ANTIEMETIC CLINICAL-TRIALS - AN EMERGING CONSENSUS, Supportive care in cancer, 6(3), 1998, pp. 261-265
Authors:
OLVER I
DAVY M
WEBSTER L
EGORIN M
LUFTNER D
PARK SH
Citation: I. Olver et al., A PHASE-I TRIAL WITH PHARMACOKINETICS OF PACLITAXEL AND ALTRETAMINE FOR OVARIAN-CANCER RELAPSING FOLLOWING CISPLATIN, Annals of oncology, 9, 1998, pp. 327-327
Authors:
BASSER RL
TO LB
BEGLEY CG
MAHER D
JUTTNER C
CEBON J
MANSFIELD R
OLVER I
DUGGAN G
SZER J
COLLINS J
SCHWARTZ B
MARTY J
MENCHACA D
SHERIDAN WP
FOX RM
GREEN MD
Citation: Rl. Basser et al., RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR, Journal of clinical oncology, 16(5), 1998, pp. 1899-1908
Authors:
OLVER I
PASKA W
DEPIERRE A
SEITZ JF
STEWART DJ
GOEDHALS L
MCQUADE B
FORSTER J
WILKINSON JR
Citation: I. Olver et al., THE CONTROL OF DELAYED NAUSEA - RESPONSE, Annals of oncology, 8(6), 1997, pp. 615-616
Authors:
BELLER E
TATTERSALL M
LUMLEY T
LEVI J
DALLEY D
OLVER I
PAGE J
ABDI E
WYNNE C
FRIEDLANDER M
BOADLE D
WHEELER H
MARGRIE S
SIMES RJ
Citation: E. Beller et al., IMPROVED QUALITY-OF-LIFE WITH MEGESTROL-ACETATE IN PATIENTS WITH ENDOCRINE-INSENSITIVE ADVANCED CANCER - A RANDOMIZED PLACEBO-CONTROLLED TRIAL, Annals of oncology, 8(3), 1997, pp. 277-283
Authors:
BISHOP JF
DEWAR J
TONER G
TATTERSALL MH
OLVER I
ACKLAND S
KENNEDY I
GOLDSTEIN D
GURNEY H
WALPOLE E
LEVI J
STEPHENSON J
Citation: Jf. Bishop et al., A RANDOMIZED STUDY OF PACLITAXEL VERSUS CYCLOPHOSPHAMIDE METHOTREXATE/5-FLUOROURACIL/PREDNISONE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 24(5), 1997, pp. 5-9
Authors:
BALL D
SMITH J
BISHOP J
OLVER I
DAVIS S
OBRIEN P
BERNSHAW D
RYAN G
MILLWARD M
Citation: D. Ball et al., A PHASE-III STUDY OF RADIOTHERAPY WITH AND WITHOUT CONTINUOUS-INFUSION FLUOROURACIL AS PALLIATION FOR NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 75(5), 1997, pp. 690-697
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
AZAB M
SEYMOUR L
LOWERY K
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995), European journal of cancer, 32A, 1996, pp. 1
Authors:
OLVER I
PASKA W
DEPIERRE A
SEITZ JF
STEWART DJ
GOEDHALS L
MCQUADE B
MCRAE J
WILKINSON JR
Citation: I. Olver et al., A MULTICENTER, DOUBLE-BLIND-STUDY COMPARING PLACEBO, ONDANSETRON AND ONDANSETRON PLUS DEXAMETHASONE FOR THE CONTROL OF CISPLATIN-INDUCED DELAYED EMESIS, Annals of oncology, 7(9), 1996, pp. 945-952
Authors:
BASSER RL
TO LB
BEGLEY CG
JUTTNER CA
MAHER DW
SZER J
CEBON J
COLLINS JP
RUSSELL I
OLVER I
GILL PG
FOX RM
SHERIDAN WP
GREEN MD
Citation: Rl. Basser et al., ADJUVANT TREATMENT OF HIGH-RISK BREAST-CANCER USING MULTICYCLE HIGH-DOSE CHEMOTHERAPY AND FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Clinical cancer research, 1(7), 1995, pp. 715-721
Authors:
ZALCBERQ J
CUNNINGHAM D
RATH U
OLVER I
KERR D
VANCUTSEM E
SVENSON C
SEITZ JF
HARPER P
Citation: J. Zalcberq et al., TOMUDEX (ZD1694) HAS A HIGHER RESPONSE RATE, SIGNIFICANTLY LESS LEUKOPENIA AND MUCOSITIS AND A SIMPLER DOSING REGIMEN THAN 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) FOR ADVANCED COLORECTAL-CANCER (CRC) - FIRSTRESULTS OF A PHASE-III STUDY, European journal of cancer, 31A, 1995, pp. 701-701
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
AZAB M
SEYMOUR L
LOWERY K
ACKLAND SP
BASSER RL
CLARKE SJ
GOLDSTEIN D
GREEN MD
GRYGIEL JJ
MCKENDRICK JJ
MILLWARD MJ
OLVER IN
TATTERSALL MHN
THOMSON DB
JAKESZ R
BUSET M
TUENI EA
VANCUTSEM EJD
BAUER J
BESKA F
ADENIS A
BRUNET R
FRANCOIS E
PAILLOT B
ROUGIER P
FINK UFW
KNUTH KRA
KOENIG HJ
BOHME MWJ
WANDER HE
AMADORI D
FRASSINETI L
COCCONI G
PASSALACQUA R
FRIGERIO F
BARNI S
LUPORINI G
LABIANCA R
MARINI G
ZANIBONI A
KLEPP O
TVEIT KM
WIST E
CANDEIAS OFR
GOUVEIA JGP
MARQUES JCN
OLIVEIRA JML
CAVALLI F
DELMORE GD
GOEDHALS L
VOROBIOF DA
ESTEVE AAI
AGUILAR EA
TORRES AA
RUIPEREZ AC
RUBIO ED
SUREDA BM
MANGA GP
ALFONSO PG
GUSTAVSSON B
JEPPSON B
MALMBERG M
STARKHAMMAR H
SVENSSON JH
KEIZER HJ
SCHORNAGEL JH
OBRIEN M
HARPER PG
KERR DJ
SCARFFE JH
TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
Authors:
OLVER I
GREEN M
PETERS W
ZIMET A
TONER G
BISHOP J
KETELBEY W
RASTOGI R
BIRKHOFER M
Citation: I. Olver et al., A PHASE-II TRIAL OF ZENIPLATIN IN METASTATIC MELANOMA, American journal of clinical oncology, 18(1), 1995, pp. 56-58
Authors:
PHILIPS KA
FRIEDLANDER M
OLVER I
EVANS B
SMITH J
FITZHARRIS B
MCCRYSTAL M
JOUGHIN J
BISHOP J
Citation: Ka. Philips et al., AUSTRALASIAN MULTICENTER PHASE-II STUDY OF PACLITAXEL (TAXOL) IN RELAPSED OVARIAN-CANCER, Australian and New Zealand Journal of Medicine, 25(4), 1995, pp. 337-343
Authors:
MAHER DW
LIESCHKE GJ
GREEN M
BISHOP J
STUARTHARRIS R
WOLF M
SHERIDAN WP
KEFFORD RF
CEBON J
OLVER I
MCKENDRICK J
TONER G
BRADSTOCK K
LIESCHKE M
CRUICKSHANK S
TOMITA DK
HOFFMAN EW
FOX RM
MORSTYN G
Citation: Dw. Maher et al., FILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(7), 1994, pp. 492-501
Risultati:
1-15
|